Premaitha Health has revealed that David Evans, Non-executive Chairman, has stepped down from the Board with immediate effect. Adam Reynolds, Non-executive Director, will become Non-executive Chairman on an interim basis until such time as a new permanent chairman is appointed.
Adam Reynolds, Non-executive Chairman, commented:
“On behalf of the Board I would like to thank David Evans for his enormous contribution to Premaitha. David has provided valuable counsel since the Company’s admission to AIM in 2014 and leading up to our successful commercialisation of the IONA test, which is now being used in multiple countries around the world as a safe and fast non-invasive prenatal screening system.”